Vardhaman Labs.

Vardhaman_Labs.16 Aug 2019

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Vardhaman Labs.

Vardhaman Labs.

Pharmaceuticals

Vardhaman_Labs.16 Aug 2019

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
11-Jul-2022	BC	Trading Members of the Exchange are hereby informed that the undermentioned 37 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with	13-Jul-2022
26-Sep-2019	BC	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2018/77 dated May 3, 2018 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP)	18-Oct-2019
19-Sep-2019	BC	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2018/77 dated May 3, 2018 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP) f	11-Oct-2019
08-Feb-2019	BC	VARDHAMAN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve This is to bring to your kind att	14-Feb-2019
06-Nov-2018	BC	VARDHAMAN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve This is to bring to your kind att	14-Nov-2018

No Rights has been declared by Vardhaman_Labs.

Book Closure

Record Date	Split Date	Purpose
13-Jul-2022	-	Trading Members of the Exchange are hereby informed that the undermentioned 37 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with
18-Oct-2019	-	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2018/77 dated May 3, 2018 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP)
11-Oct-2019	-	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2018/77 dated May 3, 2018 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP) f
14-Feb-2019	-	VARDHAMAN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve This is to bring to your kind att
14-Nov-2018	-	VARDHAMAN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve This is to bring to your kind att

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Vardhaman Laboratories Ltd ₹0.51(0.00/0.00%)	0.51	+0.00	0.21	-22.73	0.00	0.11
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 18	Sep 18	Jun 18	Mar 18	Dec 17	Sep 17
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.01	0.01	0.00
Total Income	0.00	0.00	0.00	0.01	0.01	0.00
Total Expenditure	0.01	0.01	0.00	0.01	0.01	0.00
PBIDT	-0.01	-0.01	0.00	-0.01	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.01	-0.01	0.00	-0.01	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.01	-0.01	0.00	-0.01	0.00	0.00
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.01	-0.01	0.00	-0.01	0.00	0.00

EPS (Unit Curr.)	-0.01	-0.01	-0.01	-0.02	0.01	-0.01
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	-0.02	0.01	-0.01
Calculated EPS (Unit Curr.)	-0.01	-0.01	-0.01	-0.02	0.01	-0.01
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	-0.02	0.01	-0.01
Calculated EPS (Ann.) (Unit Curr.)	-0.06	-0.05	-0.04	-0.08	0.03	-0.03
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	-0.08	0.03	-0.03
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.12	4.12	4.12	4.12	4.12	4.12
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14	Mar 13
SOURCES OF FUNDS :
Share Capital	4.12	4.12	4.12	4.12	4.12	4.12
Reserves Total	-2.13	-2.09	-2.05	-2.02	-1.99	-1.97
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	1.99	2.03	2.07	2.10	2.13	2.15
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.99	2.03	2.07	2.10	2.13	2.15
APPLICATION OF FUNDS :
Gross Block	0.00	0.00	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	1.56	1.56	1.55	1.55	1.90	2.05
Cash and Bank	0.43	0.48	0.53	0.54	0.23	0.11
Loans and Advances	0.05	0.01	0.01	0.02	0.00	0.00
Total Current Assets	2.03	2.05	2.10	2.11	2.14	2.16
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.03	0.01	0.02	0.00	0.01	0.01
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.03	0.01	0.02	0.00	0.01	0.01
Net Current Assets	2.00	2.04	2.08	2.11	2.13	2.16
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	2.00	2.04	2.08	2.11	2.13	2.16
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
Cash and Cash Equivalents at Beginning of the year	0.49	0.54	0.54	0.23	0.11
Net Cash from Operating Activities	0.02	-0.04	0.00	0.31	0.12
Net Cash Used In Investing Activities	0.00	0.00	0.00	0.00	0.00
Net Cash Used In Financing Activities	0.00	0.00	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	0.02	-0.04	0.00	0.31	0.12
Cash And Cash Equivalents At End Of The Year	0.52	0.49	0.53	0.54	0.23

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

37.20%

FII Shareholding

0.00%

DII Shareholding

0.11%

Public Shareholding

62.69%

**Promoter pledged shareholding 37.20%

About Vardhaman Laboratories Ltd

Vardhaman Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 0.21 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.01 crores for the quarter ended December 2018. The company management includes Dharamchand Shah, Dharamchand Shah,Sunil D Shah,Sumedh Shah,Dayanand Naik,Umesh Patil,Rajendra Petare (Vardhaman Laboratories Ltd) among others.

Chairman

Dharamchand Shah

Registered office

1393 Peth Bhag,High School Road,Sangli,Maharashtra,416416

FAX :91-233-375887

Background

Incorporation Year1985

Face Value₹10

Market Lot1

How to buy Vardhaman Labs. shares on nse?

To buy Vardhaman Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Vardhaman Labs. share price today?

The Vardhaman Labs. shares price on nse is Rs.0.51 today.

What is the market cap of Vardhaman Labs. shares on BSE ?

The company has a market capitalization of Rs.0.21Cr

What is the PE & PB ratio of Vardhaman Labs. shares ?

PE is 0 and PB is 0.11

What is the 52 Week High and Low of Vardhaman Labs. shares?

Vardhaman Labs. stock price high: Rs.0.51 Vardhaman Labs. stock price low: Rs.0